Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Al Mayadeen correspondent: The US vetoed a UNSC resolution calling for a ceasefire in Gaza, arguing it does not condemn Hamas nor grant "Israel" the right to “self-defense.”
Israeli occupation forces issue a new bombing threat against civilian buildings in the Southern Lebanese towns of Borj Qalaouiye and Chehabiyeh.
Sources to Al Mayadeen: Extending the snapback mechanism deadline will test how independent Europeans truly are from the US.
Sources to Al Mayadeen: Activating the snapback mechanism will nullify the Cairo Agreement, shut the door on cooperation between the IAEA and Tehran, and bar inspections.
Sources to Al Mayadeen: The diplomatic window remains open, but signs of activating the snapback sanctions mechanism on Iran are increasing.
Sources to Al Mayadeen: Although the Cairo Agreement meets an important part of European demands, they have begun speaking of new conditions in recent communications.
Sources to Al Mayadeen: European countries show no independence in their stance toward Iran during the talks.
Israeli occupation forces issued bombing threats to bomb civilian buildings in Southern Lebanon.
Israeli media: Person behind shooting operation at Allenby Crossing is a Jordanian Army soldier.
Israeli media citing Emergency Services: Both wounded in Allenby shooting operation now dead.

New cystic fibrosis treatment may end suffering for patients

  • By Al Mayadeen English
  • Source: Agencies
  • 25 Sep 2022 14:53
4 Min Read

Trikafta/Kaftrio pill treatments are the new breakthrough in cystic fibrosis treatments as it may restore the patients' abilities to live normally again without organ transplants.

  • x
  • The triple-pill treatment (Trikafta)
    The triple-pill treatment (Trikafta)

While waiting for a lung transplant, cystic fibrosis patient David Fiant says he was on oxygen therapy and had a six-hour daily care regime, as well as three to four weeks of antibiotic infusions a year as part of his treatment that was so exhaustive he "could no longer tell if I was living to heal myself or healing myself to live."

He later became one of the first participants in the new triple-drug treatment praised as a pivotal moment for those suffering from the rare disorder, which was life-changing that when his doctor examined him after he started the therapy, he could hear air circulating in his lungs for the first time. 

Fiant described his trial with the new drug treatment, saying, "I took my first dose of the medicine one morning. By 3 pm I was feeling first effects," adding that he was able to shower by himself, climb 15 steps at once, and take his daughter "to buy comic books".

Following his triumph over his life-threatening condition, Fiant has since then become the president of the French non-profit Vaincre la Mucoviscidose (Defeat Cystic Fibrosis). Although he stated that the results were "spectacular", he underlined that a complete cure has still not been found for cystic fibrosis. 

Life expectancies at risk

The condition, which is transmitted by genetic inheritance, builds up sticky mucus in the lungs, digestive tract, and other organs leading to difficulty breathing and long-term complications, such as infection which can often be fatal. 

Related News

Heal Palestine slams US for blocking Gaza kids’ lifesaving visas

How Laura Loomer halted lifesaving medical visas for Gaza’s children

As a result, life expectancies are significantly impacted and become shorter than expected. More than 70,000 people worldwide suffer from this disease. 

Sold on the market as Trikafta in the US after its approval in 2019, its effects have proven to be major with the life expectancy of cystic fibrosis patients born between 2017 and 2021 in the US now being 53, as opposed to 38 a decade ago, according to the US non-profit organization the Cystic Fibrosis Foundation.

The triple-pill treatment was then approved by the European Union's medicines agency and by the UK in August 2020, where it was sold as Kaftrio. Both varieties have been applauded for targeting the underlying cause of the disease and repairing the mutation in the CFTR gene.

Its demand does have a downside. Out of the 7,500 cystic fibrosis patients in France, only 40% are able to use the treatment.

The reason is that the treatment has not been approved for children under the age of six, and 15% of patients have a genetic profile that the treatment won't work for. Moreover, approximately 900 individuals who received transplants of lungs or livers are also deemed ineligible.

"Do not forget us"

Sabrina Perquis, a cystic fibrosis patient in France, was excited to take the treatment until she found out that she could not use Kaftrio because of a transplant she had 15 years ago, calling it "a tough blow." 

"When you have had a transplant you live with a sword of Damocles hanging over your head because rejection is always possible," she said, adding, "We are asking not to be forgotten. Research must continue to find a solution for all patients."

Although several research studies are taking place and are at varying stages of development, questions still remain, such as whether the treatment completely blocks the disease's development or if it solely impedes it, according to Vaincre la Mucoviscidose Vice-President Pierre Foucaud. 

Cystic fibrosis patients who had an organ transplant fell from 21 to just 2 per quarter in France from the years 2019 to 2021, fueled by hopes that the Kaftrio treatment would make the transplant operation unnecessary. "But will these transplants merely be delayed by 10 to 15 years?" Foucaud asked. "We don't know," adding that Kaftrio has "opened up a tremendous hope for all patients" but more work needs to be conducted. 

  • Medical treatment
  • US
  • cystic fibrosis
  • European Union

Most Read

Why is Choose Love using a firm with British and US intelligence connections to run a pro-Palestine musical event? (Al Mayadeen English; Illustrated by Batoul Chamas)

Together for Palestine: Troubling questions about the organisers of this huge event

  • Opinion
  • 17 Sep 2025
Uprising against Volker Turk at the Human Rights Council over Gaza.

Uprising against Volker Turk at the Human Rights Council over Gaza

  • Politics
  • 12 Sep 2025
A screengrab from the ad played on Fox News. (X Screengrab)

Fox airs ad warning Trump not to let Netanyahu 'play' him on Gaza

  • US & Canada
  • 11 Sep 2025
Lapid: Egypt’s Arab Force plan a 'severe blow' to normalization

Lapid: Egypt’s Arab Force plan a 'severe blow' to normalization

  • Palestine
  • 14 Sep 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
A Hezbollah supporter who lost his sight in a pager attack carried out by "Israel" on Sept. 17, 2024, covers his eyes with a red headband inscribed with the name "Hussein" during Ashoura, July 6, 2025 (AP)
Politics

'We Have Recovered': Lebanon marks 1st anniversary of Pager Attack

The Arab neighborhood of El Za'im, on the outskirts of east Occupied Al-Quds in the West Bank, near where Israeli government says housing units will be built as part of the E1 settlement project, Thursday, August 21, 2025. (AP Photo/Ohad Zwigenberg)
Palestine

'Israel’s' deliberate policies drive West Bank economy toward collapse

Ben & Jerry's ice cream shop, Wednesday, Feb. 26, 2025, in Cambridge, Mass. (AP Photo/Charles Krupa)
Politics

Ben & Jerry’s co-founder resigns over parent company curbing activism

Trump’s approval rating falls to new low in second term: Poll
US & Canada

Trump’s approval rating falls to new low in second term: Poll

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS